Hypoxia and inflammatory factor preconditioning enhances the immunosuppressive properties of human umbilical cord mesenchymal stem cells.

IF 3.6 3区 医学 Q3 CELL & TISSUE ENGINEERING
Hang Li, Xiao-Qing Ji, Shu-Ming Zhang, Ri-Hui Bi
{"title":"Hypoxia and inflammatory factor preconditioning enhances the immunosuppressive properties of human umbilical cord mesenchymal stem cells.","authors":"Hang Li, Xiao-Qing Ji, Shu-Ming Zhang, Ri-Hui Bi","doi":"10.4252/wjsc.v15.i11.999","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mesenchymal stem cells (MSCs) have great potential for the treatment of various immune diseases due to their unique immunomodulatory properties. However, MSCs exposed to the harsh inflammatory environment of damaged tissue after intravenous transplantation cannot exert their biological effects, and therefore, their therapeutic efficacy is reduced. In this challenging context, an <i>in vitro</i> preconditioning method is necessary for the development of MSC-based therapies with increased immunomodulatory capacity and transplantation efficacy.</p><p><strong>Aim: </strong>To determine whether hypoxia and inflammatory factor preconditioning increases the immunosuppressive properties of MSCs without affecting their biological characteristics.</p><p><strong>Methods: </strong>Umbilical cord MSCs (UC-MSCs) were pretreated with hypoxia (2% O<sub>2</sub>) exposure and inflammatory factors (interleukin-1β, tumor necrosis factor-α, interferon-γ) for 24 h. Flow cytometry, polymerase chain reaction, enzyme-linked immunosorbent assay and other experimental methods were used to evaluate the biological characteristics of pretreated UC-MSCs and to determine whether pretreatment affected the immunosuppressive ability of UC-MSCs in coculture with immune cells.</p><p><strong>Results: </strong>Pretreatment with hypoxia and inflammatory factors caused UC-MSCs to be elongated but did not affect their viability, proliferation or size. In addition, pretreatment significantly decreased the expression of coagulation-related tissue factors but did not affect the expression of other surface markers. Similarly, mitochondrial function and integrity were retained. Although pretreatment promoted UC-MSC apoptosis and senescence, it increased the expression of genes and proteins related to immune regulation. Pretreatment increased peripheral blood mononuclear cell and natural killer (NK) cell proliferation rates and inhibited NK cell-induced toxicity to varying degrees.</p><p><strong>Conclusion: </strong>In summary, hypoxia and inflammatory factor preconditioning led to higher immunosuppressive effects of MSCs without damaging their biological characteristics.</p>","PeriodicalId":23775,"journal":{"name":"World journal of stem cells","volume":"15 11","pages":"999-1016"},"PeriodicalIF":3.6000,"publicationDate":"2023-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696190/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of stem cells","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4252/wjsc.v15.i11.999","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Mesenchymal stem cells (MSCs) have great potential for the treatment of various immune diseases due to their unique immunomodulatory properties. However, MSCs exposed to the harsh inflammatory environment of damaged tissue after intravenous transplantation cannot exert their biological effects, and therefore, their therapeutic efficacy is reduced. In this challenging context, an in vitro preconditioning method is necessary for the development of MSC-based therapies with increased immunomodulatory capacity and transplantation efficacy.

Aim: To determine whether hypoxia and inflammatory factor preconditioning increases the immunosuppressive properties of MSCs without affecting their biological characteristics.

Methods: Umbilical cord MSCs (UC-MSCs) were pretreated with hypoxia (2% O2) exposure and inflammatory factors (interleukin-1β, tumor necrosis factor-α, interferon-γ) for 24 h. Flow cytometry, polymerase chain reaction, enzyme-linked immunosorbent assay and other experimental methods were used to evaluate the biological characteristics of pretreated UC-MSCs and to determine whether pretreatment affected the immunosuppressive ability of UC-MSCs in coculture with immune cells.

Results: Pretreatment with hypoxia and inflammatory factors caused UC-MSCs to be elongated but did not affect their viability, proliferation or size. In addition, pretreatment significantly decreased the expression of coagulation-related tissue factors but did not affect the expression of other surface markers. Similarly, mitochondrial function and integrity were retained. Although pretreatment promoted UC-MSC apoptosis and senescence, it increased the expression of genes and proteins related to immune regulation. Pretreatment increased peripheral blood mononuclear cell and natural killer (NK) cell proliferation rates and inhibited NK cell-induced toxicity to varying degrees.

Conclusion: In summary, hypoxia and inflammatory factor preconditioning led to higher immunosuppressive effects of MSCs without damaging their biological characteristics.

缺氧和炎症因子预处理增强人脐带间充质干细胞的免疫抑制特性。
背景:间充质干细胞(MSCs)由于其独特的免疫调节特性,在多种免疫疾病的治疗中具有巨大的潜力。然而,骨髓间充质干细胞在静脉移植后暴露于损伤组织的恶劣炎症环境中,无法发挥其生物学效应,从而降低了其治疗效果。在这种具有挑战性的背景下,体外预处理方法对于开发具有增强免疫调节能力和移植功效的基于msc的疗法是必要的。目的:探讨缺氧和炎症因子预处理是否在不影响骨髓间充质干细胞生物学特性的前提下增加其免疫抑制特性。方法:脐带间充质干细胞(UC-MSCs)经缺氧(2% O2)暴露和炎症因子(白细胞介素-1β、肿瘤坏死因子-α、干扰素-γ)预处理24 h,采用流式细胞术、聚合酶链反应、酶联免疫吸附法等实验方法评价预处理后的UC-MSCs生物学特性,并确定预处理是否影响UC-MSCs与免疫细胞共培养的免疫抑制能力。结果:缺氧和炎症因子预处理使UC-MSCs延长,但不影响其活力、增殖和大小。此外,预处理显著降低了凝血相关组织因子的表达,但不影响其他表面标志物的表达。同样,线粒体功能和完整性得以保留。预处理虽然促进了UC-MSC的凋亡和衰老,但增加了免疫调节相关基因和蛋白的表达。预处理可提高外周血单核细胞和NK细胞的增殖率,不同程度地抑制NK细胞诱导的毒性。结论:综上所述,缺氧和炎症因子预处理使MSCs具有较高的免疫抑制作用,但不破坏其生物学特性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World journal of stem cells
World journal of stem cells Biochemistry, Genetics and Molecular Biology-Molecular Biology
CiteScore
7.80
自引率
4.90%
发文量
750
期刊介绍: The World Journal of Stem Cells (WJSC) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of stem cells. It was launched on December 31, 2009 and is published monthly (12 issues annually) by BPG, the world''s leading professional clinical medical journal publishing company.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信